pharmacokinetic enhancement
Showing 1 - 25 of 7,430
Bictegravir in the Elderly Living With HIV (BICEP)
Active, not recruiting
- HIV-1-infection
- Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
-
Buffalo, New YorkEvergreen Health
Oct 28, 2022
Fear of Heights, Specific Phobia, Situational Trial in Bochum (Visual Feedback, Self-efficacy enhancement:, intervention)
Enrolling by invitation
- Fear of Heights
- Specific Phobia, Situational
- Visual Feedback
- +3 more
-
Bochum, GermanyMental Health Research and Treatment Center
Apr 21, 2023
Glioblastoma Trial in France (Polysiloxane Gd-Chelates based nanoparticles (AGuIX), radiotherapy, Temozolomide)
Recruiting
- Glioblastoma
- Polysiloxane Gd-Chelates based nanoparticles (AGuIX)
- +2 more
-
Brest, France
- +5 more
Jun 16, 2022
Frailty Trial (Sleep Health Enhancement Intervention)
Not yet recruiting
- Frailty
- Sleep Health Enhancement Intervention
- (no location specified)
Jul 28, 2023
Interstitial Lung Disease Trial in Boston ([68Ga]CBP8, Dotarem)
Recruiting
- Interstitial Lung Disease
-
Boston, MassachusettsMassachusetts General Hospital
Aug 22, 2022
Acquired Brain Injury, Mild Cognitive Impairment, Mild Neurocognitive Disorder Trial in Boston (Cognitive Computerized Training)
Recruiting
- Acquired Brain Injury
- +2 more
- Cognitive Computerized Training
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 8, 2023
Glioblastoma Trial in Birmingham (Point-of-care Portable Perfusion Phantom (P4))
Recruiting
- Glioblastoma
- Point-of-care Portable Perfusion Phantom (P4)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 24, 2023
Individualized Scanning for Coronary Artery Disease
Not yet recruiting
- Coronary Artery Disease
- Coronary Computed Tomographic Angiography
- (no location specified)
Aug 9, 2022
Tobacco Use, Smoking Cessation, Nicotine Dependence Trial (Ketamine Hydrochloride, Motivational enhancement therapy)
Not yet recruiting
- Tobacco Use
- +2 more
- Ketamine Hydrochloride
- Motivational enhancement therapy
- (no location specified)
Mar 21, 2023
Adolescent Drug Prevention, Evidence-based Practice Implementation Trial in Los Angeles (Project ALERT, Getting to Outcomes)
Recruiting
- Substance Abuse
- Project ALERT
- Getting to Outcomes
-
Los Angeles, CaliforniaLos Angeles Unified School District
Dec 21, 2022
Ocrelizumab on Choroid Plexus Changes in Patients With PPMS
Not yet recruiting
- Primary Progressive Multiple Sclerosis
- Ocrelizumab
-
Buffalo, New YorkBuffalo Neuroimaging Analysis Center
Jul 26, 2023
Holo CTO Proctoring Study
Completed
- Percutaneous Coronary Intervention
- Chronic Total Occlusion of Coronary Artery
- Remote proctoring using HoloLens
-
Arendal, Agder, NorwaySorlandet Hospital
Jan 31, 2023
BHB Transport, Alcohol Use Disorder Trial (Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans)
Not yet recruiting
- BHB Transport
- Alcohol Use Disorder
- Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans
- (no location specified)
Jun 30, 2023
Type 1 Diabetes Trial in Trondheim (Glucagon)
Recruiting
- Type 1 Diabetes
-
Trondheim, NorwayDepartment of Endocrinology, St. Olavs Hospital
Jul 17, 2023
Impact of Using Different Contrast Medium Strategies on Contrast Enhancement in Chest CT Trial in Oslo (Adopted contrast media
Recruiting
- Impact of Using Different Contrast Medium Strategies on Contrast Enhancement in Chest CT
- Adopted contrast media amount by using different approaches
-
Oslo, NorwayOsloMet University
Dec 7, 2022
Macrolane Retrospective Study
Completed
- Women Who Have Had Breast Enhancement With Macrolane VRF
-
Göteborg, Sweden
- +3 more
Aug 24, 2022
Brain Diseases, Epilepsy, Memory Disorders Trial in Saint Louis (Intracranial Stimulation)
Recruiting
- Brain Diseases
- +5 more
- Intracranial Stimulation
-
Saint Louis, MissouriWashington University School of Medicine
Jan 27, 2023
Healthy Subjects Trial in Shanghai (JYP0061, )
Completed
- Healthy Subjects
- JYP0061
- placebo
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Nov 16, 2023
Pharmacokinetics, Safety, Tolerability Trial in Overland Park (5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo)
Recruiting
- Pharmacokinetics
- +2 more
- 5-methoxy-N,N-dimethyltryptamine succinate salt
- Placebo
-
Overland Park, KansasAltasciences Clinical Kansas, Inc
Jan 13, 2023
Upper Respiratory Infection Trial in Seoul (Allium Cepa L. Peel Heated Water Extract, Placebo)
Active, not recruiting
- Upper Respiratory Infection
- Allium Cepa L. Peel Heated Water Extract
- Placebo
-
Seoul, Korea, Republic ofHanyang University
Dec 27, 2022
Athletic Performance Trial in San Antonio (Sports vision enhancement training curriculum)
Completed
- Athletic Performance
- Sports vision enhancement training curriculum
-
San Antonio, TexasUniversity of the Incarnate Word
Aug 11, 2023